Search This Blog

Thursday, August 8, 2019

Puma Biotechnology EPS beats by $0.42, beats on revenue

Puma Biotechnology (NASDAQ:PBYI): Q2 Non-GAAP EPS of -$0.57 beats by $0.42; GAAP EPS of -$0.97 beats by $0.02.
Revenue of $53.9M (+6.1% Y/Y) beats by $0.5M.
Shares +0.1%.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)